Search

Your search keyword '"CAUDA, ROBERTO"' showing total 1,401 results

Search Constraints

Start Over You searched for: Author "CAUDA, ROBERTO" Remove constraint Author: "CAUDA, ROBERTO"
1,401 results on '"CAUDA, ROBERTO"'

Search Results

1. GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial

2. Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)

3. Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function

4. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

5. A real-time integrated framework to support clinical decision making for covid-19 patients

8. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

9. RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies

10. Sarilumab use in severe SARS-CoV-2 pneumonia

12. SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy

13. Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages

14. Genetic and structural genome-based survey reveals the low potential for epidemiological expansion of the SARS-CoV-2 XBB.1.5 sublineage

20. Genetic and structural genome-based survey reveals the low potential for epidemiological expansion of the SARS-CoV-2 XBB.1.5 sublineage

21. Cutaneous diphtheria most likely due to exposure in a detention camp in Libya

22. GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomised placebo-controlled phase 2 trial (COVITAR)

23. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

25. Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor–Based Regimen: The “STORE” Study

26. Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion

27. The value of electrostatic potentials of the spike receptor binding and N-terminal domains in addressing transmissibility and infectivity of SARS-CoV-2 variants of concern

28. COVID-19 atypical Parsonage-Turner syndrome: a case report

29. Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5

30. Genome‐based comparison between the recombinant SARS‐CoV‐2 XBB and its parental lineages

31. Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)

32. Malnutrition in COVID-19 survivors: prevalence and risk factors

35. Colonic histoplasmosis

36. Liver fibrosis may lower PSA levels: A further reason to be wary in prostate cancer screening in men with HIV?

38. Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages

39. Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion

40. 415. Epidemiological Evaluation of Antibiotic Resistance and Subsequent Effect on Healthcare Resource Utilization among Subjects with Pseudomonas aeruginosa Infections in Italy

43. People Living with HIV in the COVID-19 Era: A Case Report

44. A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19

Catalog

Books, media, physical & digital resources